Pharmacogenomics and Pain - Policy and Ethics

Author: Michael E. Schatman

A specialist in public policy and bioethics considers the conundrum of gaining insurance coverage for this cost-efficient but expensive paradigm change to prescribing decisions, as well as some of the ethical issues associated with the practice of pharmacogenomic testing.

Share:

Related Content